Insights

Access our latest insights & resources

Filters

Sector: Healthcare

European Health Care Equipment & Services: Receding Headwinds

European Health Care Equipment & Services: Receding Headwinds

Research, Fundamental
We see easing headwinds for the European Health Care Equipment & Services industry...
Read more
Revvity: Revitalized for Stronger Growth

Revvity: Revitalized for Stronger Growth

Research, Fundamental
Rebranded as Revvity, it aims at becoming a high growth, high margin firm...
Read more
Health Care REITs Poised for Healthy Returns

Health Care REITs Poised for Healthy Returns

Video, Fundamental
The aging US population and increasing healthcare expenditures...
Read more
[CVS, CI, UNH, ELV]: Entrenchment of PBM Overhang with More Bills Expected

[CVS, CI, UNH, ELV]: Entrenchment of PBM Overhang with More Bills Expected

Research, Policy
No relief for PBMs [CVS (CVS), Cigna (CI),...
Read more
May 2023 PDUFA Calendar

May 2023 PDUFA Calendar

Research, Policy
Delays in approvals due to disrupted work schedules at FDA because of the coronavirus...
Read more
Silk Road (SILK): Competition & Coverage

Silk Road (SILK): Competition & Coverage

Research, Policy
Amid investor fears of competitive risks to Silk Road Medical’s (SILK)’s TCAR procedure...
Read more
April 2023 PDUFA Calendar

April 2023 PDUFA Calendar

Research, Policy
Disrupted work schedules at FDA result in approval delays...
Read more
Advisory Committee’s Split Decision on Biogen’s Tofersen

Advisory Committee’s Split Decision on Biogen’s Tofersen

Research, Policy
We expect the FDA to grant accelerated approval of Biogen's (BIIB) ALS treatment...
Read more
Mitigation Expectations for Medicare Advantage Rate Notice

Mitigation Expectations for Medicare Advantage Rate Notice

Research, Policy
Size of Medicare Advantage mitigation may be less than earlier expectations...
Read more
European Pharma: Top Picks as Growth Slows; New Launches and Core Products are Key

European Pharma: Top Picks as Growth Slows; New Launches and Core Products are Key

Research, Fundamental
How European Pharma fared versus consensus estimates...
Read more